|
Market Closed -
Sao Paulo
01:47:54 03/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 79.54 BRL | 0.00% |
|
-2.19% | +20.59% |
| 02/09 | UK regulator suspends rare-disease drug Tavneos for new patients over unreliable data | RE |
| 01/09 | Vertex Names Jonathan Poole Finance Chief as Crinetics Buy Closes | DJ |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.04% | -1.40% | +3.41% | +7.49% | +7.90% | +57.16% | +107.74% | +346.81% | +1,377.01% | 1,034B | |
| +1.17% | +4.76% | +9.44% | +24.72% | +34.54% | +56.42% | +73.28% | +59.07% | +132.51% | 663B | |
| -0.58% | +0.80% | +6.16% | +19.84% | +13.88% | +22.82% | +78.10% | +133.12% | +302.74% | 462B | |
| +2.09% | -3.20% | +0.82% | +15.11% | +8.62% | +36.07% | +37.41% | -2.46% | +46.77% | 344B | |
| 0.00% | +3.26% | +3.73% | +16.21% | +19.82% | +29.76% | +46.97% | +55.50% | +68.79% | 307B | |
| +1.42% | -0.72% | -3.85% | -8.08% | -11.92% | +2.03% | +13.51% | +41.00% | +145.95% | 251B | |
| +0.29% | +1.63% | +17.22% | +31.31% | +35.69% | +56.46% | +74.84% | +96.19% | +159.96% | 239B | |
| -0.03% | -1.11% | -1.62% | +8.61% | -7.29% | -15.87% | -53.65% | -5.01% | +97.87% | 207B | |
| +1.08% | +1.59% | +15.30% | +17.23% | +23.20% | +33.83% | +101.20% | +110.14% | +94.17% | 186B | |
| -0.72% | +2.82% | +15.10% | +13.69% | +15.70% | +16.22% | -18.57% | -38.49% | -17.14% | 165B | |
| +0.22% | +1.90% | +18.53% | +30.26% | +23.07% | +40.68% | +60.21% | +181.73% | +482.54% | 141B | |
| +0.64% | +1.70% | +4.00% | +24.43% | +26.23% | +43.35% | +12.29% | +3.78% | +19.54% | 138B | |
| -1.15% | -2.58% | +2.42% | +3.88% | -7.80% | -9.75% | -22.65% | -13.53% | +8.57% | 107B | |
| +0.27% | -1.74% | -3.37% | +2.53% | +2.30% | +29.39% | +34.51% | +1.15% | -9.78% | 101B | |
| +0.67% | -2.45% | -0.78% | -9.71% | -16.56% | +5.69% | +55.79% | +59.21% | +507.78% | 70.85B | |
| +1.44% | +0.82% | +7.16% | +21.81% | +22.19% | +30.85% | +31.00% | +60.15% | +25.44% | 58.62B | |
| +0.33% | +0.47% | +2.68% | +44.69% | +33.32% | +79.84% | -3.01% | +3.46% | -48.02% | 56.01B | |
| +0.86% | -1.67% | -15.01% | -5.04% | -22.85% | -33.27% | +10.67% | +0.22% | +178.29% | 44.63B | |
| -2.30% | -4.21% | -1.57% | +11.44% | -4.59% | -1.54% | +11.78% | - | - | 43.54B | |
| Average | +0.36% | -0.81% | +4.20% | +14.23% | +10.29% | +25.27% | +34.29% | +60.67% | +198.50% | 243.14B | |
| Weighted average by Cap. | +0.49% | -0.75% | +5.43% | +14.70% | +13.97% | +36.17% | +57.83% | +121.21% | +417.88% |
- Stock Market
- Stocks
- AMGN Stock
- AMGN34 Stock
- Sector Amgen Inc.
Select your edition
All financial news and data tailored to specific country editions
